Literature DB >> 11376085

Amplified fragment length polymorphism fingerprinting for identification of a core group of Neisseria gonorrhoeae transmitters in the population attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands.

J Spaargaren1, J Stoof, H Fennema, R Coutinho, P Savelkoul.   

Abstract

Amplified fragment length polymorphism analysis seems well suited for studying the epidemiology of isolates of Neisseria gonorrhoeae obtained from patients attending the Sexually Transmitted Disease Outpatient Clinic in Amsterdam, The Netherlands. It shows potential to identify the core group of transmitters.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11376085      PMCID： PMC88139          DOI： 10.1128/JCM.39.6.2335-2337.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

Review 1.  Amplified-fragment length polymorphism analysis: the state of an art.

Authors:  P H Savelkoul; H J Aarts; J de Haas; L Dijkshoorn; B Duim; M Otsen; J L Rademaker; L Schouls; J A Lenstra
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  The concept of core and its relevance to the epidemiology and control of sexually transmitted diseases.

Authors:  R C Brunham
Journal:  Sex Transm Dis       Date:  1991 Apr-Jun       Impact factor: 2.830

3.  DNA amplification fingerprinting for subtyping Neisseria gonorrhoeae strains.

Authors:  J J Camarena; J M Nogueira; M A Dasi; F Moreno; R Garcia; E Ledesma; J Llorca; J Hernandez
Journal:  Sex Transm Dis       Date:  1995 Mar-Apr       Impact factor: 2.830

4.  Opa-typing: a high-resolution tool for studying the epidemiology of gonorrhoea.

Authors:  M O'Rourke; C A Ison; A M Renton; B G Spratt
Journal:  Mol Microbiol       Date:  1995-09       Impact factor: 3.501

5.  Pulsed-field gel electrophoresis for genomic analysis of Neisseria gonorrhoeae.

Authors:  M Xia; W L Whittington; K K Holmes; F A Plummer; M C Roberts
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

6.  Molecular epidemiology of infections with Neisseria gonorrhoeae among visitors to a sexually transmitted diseases clinic.

Authors:  Y T van Duynhoven; B van Klingeren; M G van Santen-Verheuvel; W I van der Meijden; M J van de Laar
Journal:  Sex Transm Dis       Date:  1997-08       Impact factor: 2.830

7.  [Substantial increase in gonorrhea and syphilis among clients of Amsterdam Sexually Transmitted Diseases Clinic].

Authors:  J S Fennema; I Cairo; R A Coutinho
Journal:  Ned Tijdschr Geneeskd       Date:  2000-03-25

8.  Comparison of amplified ribosomal DNA restriction analysis, random amplified polymorphic DNA analysis, and amplified fragment length polymorphism fingerprinting for identification of Acinetobacter genomic species and typing of Acinetobacter baumannii.

Authors:  J G Koeleman; J Stoof; D J Biesmans; P H Savelkoul; C M Vandenbroucke-Grauls
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Evaluation of the discriminatory power of typing methods for Neisseria gonorrhoeae.

Authors:  M Van Looveren; C A Ison; M Ieven; P Vandamme; I M Martin; K Vermeulen; A Renton; H Goossens
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948
  9 in total
  9 in total

Review 1.  Review and international recommendation of methods for typing neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology.

Authors:  Magnus Unemo; Jo-Anne R Dillon
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

2.  Molecular epidemiology of Neisseria gonorrhoeae in Amsterdam, The Netherlands, shows distinct heterosexual and homosexual networks.

Authors:  Marion-Eliëtte Kolader; Nicole H T M Dukers; Akke K van der Bij; Mirjam Dierdorp; Johan S A Fennema; Roel A Coutinho; Sylvia M Bruisten
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Interrelationship between polymorphisms of incA, fusogenic properties of Chlamydia trachomatis strains, and clinical manifestations in patients in The Netherlands.

Authors:  Yvonne Pannekoek; Joke Spaargaren; Ankie A J Langerak; Judith Merks; Servaas A Morré; Arie van der Ende
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

4.  Molecular surveillance of clinical Neisseria gonorrhoeae isolates in Russia.

Authors:  Elena N Ilina; Nina Y Oparina; Egor A Shitikov; Alexandra D Borovskaya; Vadim M Govorun
Journal:  J Clin Microbiol       Date:  2010-07-21       Impact factor: 5.948

5.  Molecular typing of Neisseria gonorrhoeae isolates by pyrosequencing of highly polymorphic segments of the porB gene.

Authors:  Magnus Unemo; Per Olcén; Jon Jonasson; Hans Fredlund
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains.

Authors:  Magnus Unemo; Per Olcén; Torsten Berglund; Jan Albert; Hans Fredlund
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

7.  Comparison of serologic and genetic porB-based typing of Neisseria gonorrhoeae: consequences for future characterization.

Authors:  Magnus Unemo; Per Olcén; Jan Albert; Hans Fredlund
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

8.  The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology.

Authors:  Sander Ouburg; Joke Spaargaren; Janneke E den Hartog; Jolande A Land; Johan S A Fennema; Jolein Pleijster; A Salvador Peña; Servaas A Morré
Journal:  BMC Infect Dis       Date:  2005-12-20       Impact factor: 3.090

9.  Molecular Typing of Neisseria gonorrhoeae Isolates by Opa-Typing and Ribotyping in New Delhi, India.

Authors:  Pejvak Khaki; Preena Bhalla; Ahmad Mir Fayaz; Sohiela Moradi Bidhendi; Majid Esmailzadeh; Pawan Sharma
Journal:  Int J Microbiol       Date:  2009-09-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.